12 Best Airport Stocks to Invest in Now

3. Blade Air Mobility Inc. (NASDAQ:BLDE)

Number of Hedge Fund Holders: 11

A technology-driven air mobility platform, Blade Air Mobility, Inc. (NASDAQ:BLDE) offers helicopter and fixed-wing services primarily in the Northeast United States, Southern Europe, and Western Canada. It also handles hospital air transportation and logistics, as well as the transportation of human organs for transplantation and passengers. Medical and Passenger are the company’s two operating segments. The company’s medical division, which primarily comprises the transportation of human organs for transplantation and the medical teams who support these services, generates the majority of its revenue. Coordination of donor logistics and assistance in assessing possible donor organs are among its other functions. The United States accounts for a sizable amount of the company’s revenue.

Blade Air Mobility, Inc. (NASDAQ:BLDE) is positioned for long-term growth as a result of its shift to positive cash flow and higher profit margins. Higher profitability has resulted from the company’s successful exit from low-margin operations, especially in its passenger division. It is getting closer to breakeven on a GAAP basis as adjusted EBITDA starts to turn positive, and a double-digit EBITDA margin is anticipated in 2025. With $136 million in cash and no debt, its solid balance sheet offers room for future share repurchases and additional investments in its fleet of medical aircraft. Furthermore, the company’s medical transport business, which is projected to grow at a double-digit rate in 2025, benefits greatly from the expanding organ transplant industry, which is strengthened by legislation reforms and advancements in perfusion technology.

The development of eVTOL (electric vertical takeoff and landing) aircraft has the potential to transform urban air travel and greatly improve Blade Air Mobility, Inc. (NASDAQ:BLDE)’s passenger operations in the long run. Although widespread adoption of eVTOL is still a few years away, the business has a competitive advantage due to its early positioning in this market. Its medical logistics division is strengthened by its strategic alliance with OrganOx, which raises the prospect of further revenue growth.